Adverse effects of statins

In October last year we published an article by John Abramson and colleagues that questioned the evidence behind new proposals to extend the routine use of statins to people at low risk of cardiovascular disease.1 Abramson and colleagues set out to reanalyse data from the Cholesterol Treatment Tr...